# Efficacy and Safety Study of Elagolix in Women With Endometriosis

> **NCT00973973** · PHASE2 · COMPLETED · sponsor: **AbbVie** · enrollment: 137 (actual)

## Conditions studied

- Endometriosis, Pain

## Interventions

- **DRUG:** Placebo
- **DRUG:** Elagolix

## Key facts

- **NCT ID:** NCT00973973
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-12
- **Primary completion:** 2010-09-22
- **Final completion:** 2010-09-22
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00973973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00973973, "Efficacy and Safety Study of Elagolix in Women With Endometriosis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00973973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*